E3 Ligase Subunit Fbxo15 and PINK1 Kinase Regulate Cardiolipin Synthase 1 Stability and Mitochondrial Function in Pneumonia

Cell Reports

Volumn 7, Issue 2, 2014, Pages 476-487

  Chen, BillB ^a   Coon, Tiffany A ^a   Glasser, Jennifer R ^a   Zou, Chunbin ^a   Ellis, Bryon ^a   Das, Tuhin ^a   McKelvey, Alison C ^a   Rajbhandari, Shristi ^a   Lear, Travis ^a   Kamga, Christelle ^b   Shiva, Sruti ^b   Li, Chenjian ^d   Pilewski, Joseph M ^a   Callio, Jason ^a   Chu, Charleen T ^a   Ray, Anuradha ^a   Ray, Prabir ^a   Tyurina, Yulia Y ^c   Kagan, Valerian E ^c   Mallampalli, Rama K ^a,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; CARDIOLIPIN SYNTHASE 1; F BOX PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN FBXO15; PROTEIN PINK1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; FBX15 PROTEIN, MOUSE; PROTEIN KINASE; PROTEIN SUBUNIT; PTEN-INDUCED PUTATIVE KINASE;

ARTICLE; EPITHELIUM; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN TARGETING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UBIQUITINATION; UPREGULATION; ADOLESCENT; ADULT; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; CELL LINE; CHILD; ENZYME STABILITY; FEMALE; GENETICS; MALE; METABOLISM; MIDDLE AGED; MOUSE; PROTEIN SUBUNIT;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, CD86; CASE-CONTROL STUDIES; CELL LINE; CELLS, CULTURED; CHILD; ENZYME STABILITY; F-BOX PROTEINS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MITOCHONDRIA; PNEUMONIA; PROTEIN KINASES; PROTEIN SUBUNITS;

EID: 84899633940     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.02.048     Document Type: Article

References (64)

1. Blom N., Gammeltoft S., Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J.Mol. Biol. 1999, 294:1351-1362.
2. Bonifati V. Genetics of Parkinson's disease. Minerva Med. 2005, 96:175-186.
3. Brealey D., Brand M., Hargreaves I., Heales S., Land J., Smolenski R., Davies N.A., Cooper C.E., Singer M. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
4. Büeler H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp. Neurol. 2009, 218:235-246.
5. Cardozo T., Pagano M. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 2004, 5:739-751.
6. Cenciarelli C., Chiaur D.S., Guardavaccaro D., Parks W., Vidal M., Pagano M. Identification of a family of human F-box proteins. Curr. Biol. 1999, 9:1177-1179.
7. Chang S.C., Heacock P.N., Mileykovskaya E., Voelker D.R., Dowhan W. Isolation and characterization of the gene (CLS1) encoding cardiolipin synthase in Saccharomyces cerevisiae. J.Biol. Chem. 1998, 273:14933-14941.
8. Chen B.B., Mallampalli R.K. Masking of a nuclear signal motif by monoubiquitination leads to mislocalization and degradation of the regulatory enzyme cytidylyltransferase. Mol. Cell. Biol. 2009, 29:3062-3075.
9. Chen D., Zhang X.Y., Shi Y. Identification and functional characterization of hCLS1, a human cardiolipin synthase localized in mitochondria. Biochem. J. 2006, 398:169-176.
10. Chen B.B., Coon T.A., Glasser J.R., Mallampalli R.K. Calmodulin antagonizes a calcium-activated SCF ubiquitin E3 ligase subunit, FBXL2, to regulate surfactant homeostasis. Mol. Cell. Biol. 2011, 31:1905-1920.
11. Choi S.Y., Gonzalvez F., Jenkins G.M., Slomianny C., Chretien D., Arnoult D., Petit P.X., Frohman M.A. Cardiolipin deficiency releases cytochrome c from the inner mitochondrial membrane and accelerates stimuli-elicited apoptosis. Cell Death Differ. 2007, 14:597-606.
12. Crapo J.D., Peters-Golden M., Marsh-Salin J., Shelburne J.S. Pathologic changes in the lungs of oxygen-adapted rats: a morphometric analysis. Lab. Invest. 1978, 39:640-653.
13. Crapo J.D., Barry B.E., Foscue H.A., Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am. Rev. Respir. Dis. 1980, 122:123-143.
14. Dagda R.K., Cherra S.J., Kulich S.M., Tandon A., Park D., Chu C.T. Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J.Biol. Chem. 2009, 284:13843-13855.
15. Dagda R.K., Gusdon A.M., Pien I., Strack S., Green S., Li C., Van Houten B., Cherra S.J., Chu C.T. Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease. Cell Death Differ. 2011, 18:1914-1923.
16. Deng H., Dodson M.W., Huang H., Guo M. The Parkinson'sdisease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl. Acad. Sci. USA 2008, 105:14503-14508.
17. Folch J., Lees M., Sloane Stanley G.H. A simple method for theisolation and purification of total lipides from animal tissues. J.Biol. Chem. 1957, 226:497-509.
18. Friedman J.R., Lackner L.L., West M., DiBenedetto J.R., Nunnari J., Voeltz G.K. ER tubules mark sites of mitochondrial division. Science 2011, 334:358-362.
19. Haslinger B., Strangfeld K., Peters G., Schulze-Osthoff K., Sinha B. Staphylococcus aureus alpha-toxin induces apoptosis in peripheral blood mononuclear cells: role of endogenous tumour necrosis factor-alpha and the mitochondrial death pathway. Cell. Microbiol. 2003, 5:729-741.
20. Hochstrasser M. Biochemistry. All in the ubiquitin family. Science 2000, 289:563-564.
21. Hostetler K.Y. Effect of thyroxine on the activity of mitochondrial cardiolipin synthase in rat liver. Biochim. Biophys. Acta 1991, 1086:139-140.
22. Houtkooper R.H., Akbari H., van Lenthe H., Kulik W., Wanders R.J., Frentzen M., Vaz F.M. Identification and characterization of human cardiolipin synthase. FEBS Lett. 2006, 580:3059-3064.
23. Ilyin G.P., Rialland M., Glaise D., Guguen-Guillouzo C. Identification of a novel Skp2-like mammalian protein containing F-box and leucine-rich repeats. FEBS Lett. 1999, 459:75-79.
24. Jiang F., Gu Z., Granger J.M., Greenberg M.L. Cardiolipin synthase expression is essential for growth at elevated temperature and is regulated by factors affecting mitochondrial development. Mol. Microbiol. 1999, 31:373-379.
25. Katayama K., Noguchi K., Sugimoto Y. FBXO15 regulates P-glycoprotein/ABCB1 expression through the ubiquitin-proteasome pathway in cancer cells. Cancer Sci. 2013, 104:694-702.
26. Loiacono L.A., Shapiro D.S. Detection of hypoxia at the cellular level. Crit. Care Clin. 2010, 26:409-421.
27. Lu B., Xu F.Y., Jiang Y.J., Choy P.C., Hatch G.M., Grunfeld C., Feingold K.R. Cloning and characterization of a cDNA encoding human cardiolipin synthase (hCLS1). J.Lipid Res. 2006, 47:1140-1145.
28. Lu B., Xu F.Y., Taylor W.A., Feingold K.R., Hatch G.M. Cardiolipin synthase-1 mRNA expression does not correlate with endogenous cardiolipin synthase enzyme activity invitro and invivo in mammalian lipopolysaccharide models of inflammation. Inflammation 2011, 34:247-254.
29. Lutz A.K., Exner N., Fett M.E., Schlehe J.S., Kloos K., Lämmermann K., Brunner B., Kurz-Drexler A., Vogel F., Reichert A.S., et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J.Biol. Chem. 2009, 284:22938-22951.
30. Mallampalli R.K., Ryan A.J., Salome R.G., Jackowski S. Tumor necrosis factor-alpha inhibits expression of CTP:phosphocholine cytidylyltransferase. J.Biol. Chem. 2000, 275:9699-9708.
31. Massaro G.D., Gail D.B., Massaro D. Lung oxygen consumption and mitochondria of alveolar epithelial and endothelial cells. J.Appl. Physiol. 1975, 38:588-592.
32. McMillin J.B., Dowhan W. Cardiolipin and apoptosis. Biochim. Biophys. Acta 2002, 1585:97-107.
33. Meissner C., Lorenz H., Weihofen A., Selkoe D.J., Lemberg M.K. The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J.Neurochem. 2011, 117:856-867.
34. Mills R.D., Sim C.H., Mok S.S., Mulhern T.D., Culvenor J.G., Cheng H.C. Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J.Neurochem. 2008, 105:18-33.
35. Murata H., Sakaguchi M., Jin Y., Sakaguchi Y., Futami J., Yamada H., Kataoka K., Huh N.H. A new cytosolic pathway from a Parkinson disease-associated kinase, BRPK/PINK1: activation of AKT via mTORC2. J.Biol. Chem. 2011, 286:7182-7189.
36. Nie J., Hao X., Chen D., Han X., Chang Z., Shi Y. A novel function of the human CLS1 in phosphatidylglycerol synthesis and remodeling. Biochim. Biophys. Acta 2010, 1801:438-445.
37. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
38. Osiyemi O., Dickinson G. Gram-Positive Pneumonia. Curr. Infect. Dis. Rep. 2000, 2:207-214.
39. Ostrander D.B., Sparagna G.C., Amoscato A.A., McMillin J.B., Dowhan W. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J.Biol. Chem. 2001, 276:38061-38067.
40. Plun-Favreau H., Klupsch K., Moisoi N., Gandhi S., Kjaer S., Frith D., Harvey K., Deas E., Harvey R.J., McDonald N., et al. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat. Cell Biol. 2007, 9:1243-1252.
41. Pridgeon J.W., Olzmann J.A., Chin L.S., Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol. 2007, 5:e172.
42. Protti A., Singer M. Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit. Care 2006, 10:228.
43. Ragle B.E., Karginov V.A., Bubeck Wardenburg J. Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative. Antimicrob. Agents Chemother. 2010, 54:298-304.
44. Ray N.B., Durairaj L., Chen B.B., McVerry B.J., Ryan A.J., Donahoe M., Waltenbaugh A.K., O'Donnell C.P., Henderson F.C., Etscheidt C.A., et al. Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat. Med. 2010, 16:1120-1127.
45. Rello J., Sole-Violan J., Sa-Borges M., Garnacho-Montero J., Muñoz E., Sirgo G., Olona M., Diaz E. Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Crit. Care Med. 2005, 33:1983-1987.
46. Samsel R.W., Schumacker P.T. Oxygen delivery to tissues. Eur. Respir. J. 1991, 4:1258-1267.
47. Schlame M., Hostetler K.Y. Cardiolipin synthase from mammalian mitochondria. Biochim. Biophys. Acta 1997, 1348:207-213.
48. Schumacker P.T., Samsel R.W. Oxygen delivery and uptake byperipheral tissues: physiology and pathophysiology. Crit. Care Clin. 1989, 5:255-269.
49. Sha D., Chin L.S., Li L. Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-kappaB signaling. Hum. Mol. Genet. 2010, 19:352-363.
50. Shoemaker W.C., Appel P.L., Kram H.B., Bishop M.H., Abraham E. Temporal hemodynamic and oxygen transport patterns in medical patients. Septic shock. Chest 1993, 104:1529-1536.
51. Sidorova L.D., Domnikova N.P. [Prognosis of nosocomial pneumonia outcome]. Ter. Arkh. 1999, 71:37-40.
52. Singer M. Mitochondrial function in sepsis: acute phase versus multiple organ failure. Crit. Care Med. 2007, 35:S441-S448.
53. Su X., Dowhan W. Regulation of cardiolipin synthase levels in Saccharomyces cerevisiae. Yeast 2006, 23:279-291.
54. Svistunenko D.A., Davies N., Brealey D., Singer M., Cooper C.E. Mitochondrial dysfunction in patients with severe sepsis: an EPR interrogation of individual respiratory chain components. Biochim. Biophys. Acta 2006, 1757:262-272.
55. Tanaka Y., Tanaka N., Saeki Y., Tanaka K., Murakami M., Hirano T., Ishii N., Sugamura K. c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130. Mol. Cell. Biol. 2008, 28:4805-4818.
56. Tyers M., Willems A.R. One ring to rule a superfamily of E3 ubiquitin ligases. Science 1999, 284:601. 603-604.
57. Tyurina Y.Y., Kisin E.R., Murray A., Tyurin V.A., Kapralova V.I., Sparvero L.J., Amoscato A.A., Samhan-Arias A.K., Swedin L., Lahesmaa R., et al. Global phospholipidomics analysis reveals selective pulmonary peroxidation profiles upon inhalation of single-walled carbon nanotubes. ACS Nano 2011, 5:7342-7353.
58. Unoki M., Nakamura Y. Growth-suppressive effects of BPOZ andEGR2, two genes involved in the PTEN signaling pathway. Oncogene 2001, 20:4457-4465.
59. Valente E.M., Salvi S., Ialongo T., Marongiu R., Elia A.E., Caputo V., Romito L., Albanese A., Dallapiccola B., Bentivoglio A.R. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neurol. 2004, 56:336-341.
60. Vincow E.S., Merrihew G., Thomas R.E., Shulman N.J., Beyer R.P., MacCoss M.J., Pallanck L.J. The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover invivo. Proc. Natl. Acad. Sci. USA 2013, 110:6400-6405.
61. Watkins R.R., David M.Z., Salata R.A. Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus. J.Med. Microbiol. 2012, 61:1179-1193.
62. Xu F.Y., McBride H., Acehan D., Vaz F.M., Houtkooper R.H., Lee R.M., Mowat M.A., Hatch G.M. The dynamics of cardiolipin synthesis post-mitochondrial fusion. Biochim. Biophys. Acta 2010, 1798:1577-1585.
63. Zheng N., Schulman B.A., Song L., Miller J.J., Jeffrey P.D., Wang P., Chu C., Koepp D.M., Elledge S.J., Pagano M., et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002, 416:703-709.
64. Ziviani E., Tao R.N., Whitworth A.J. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc. Natl. Acad. Sci. USA 2010, 107:5018-5023.